Early veno-venous haemodiafiltration for sepsis-related multiple organ failure

被引:32
作者
Page, B
Vieillard-Baron, A
Chergui, K
Peyrouset, O
Rabiller, A
Beauchet, A
Aegerter, P
Jardin, F
机构
[1] Univ Hosp Ambroise Pare, Assistance Publ Hop Paris, Med Intens Care Unit, F-92104 Boulogne, France
[2] Univ Hosp Ambroise Pare, Assistance Publ Hop Paris, Dept Biostat, F-92104 Boulogne, France
来源
CRITICAL CARE | 2005年 / 9卷 / 06期
关键词
D O I
10.1186/cc3886
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction We conducted a prospective observational study from January 1995 to December 2004 to evaluate the impact on recovery of a major advance in renal replacement therapy, namely continuous veno-venous haemodiafiltration (CVVHDF), in patients with refractory septic shock. Method CVVHDF was implemented after 6 - 12 hours of maximal haemodynamic support, and base excess monitoring was used to evaluate the improvement achieved. Of the 60 patients studied, 40 had improved metabolic acidosis after 12 hours of CVVHDF, with a progressive improvement in all failing organs; the final mortality rate in this subgroup was 30%. In contrast, metabolic acidosis did not improve in the remaining 20 patients after 12 hours of CVVHDF, and the mortality rate in this subgroup was 100%. The crude mortality rate for the whole group was 53%, which is significantly lower than the predicted mortality using Simplified Acute Physiology Score II (79%). Conclusion Early CVVHDF may improve the prognosis of sepsis-related multiple organ failure. Failure to correct metabolic acidosis rapidly during the procedure was a strong predictor of mortality.
引用
收藏
页码:R755 / R763
页数:9
相关论文
共 33 条
[1]   Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure [J].
Abid, O ;
Akça, S ;
Haji-Michael, P ;
Vincent, JL .
CRITICAL CARE MEDICINE, 2000, 28 (04) :947-949
[2]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[3]   Serial blood lactate levels can predict the development of multiple organ failure following septic shock [J].
Bakker, J ;
Gris, P ;
Coffernils, M ;
Kahn, RJ ;
Vincent, JL .
AMERICAN JOURNAL OF SURGERY, 1996, 171 (02) :221-226
[4]   Acute renal failure: time for consensus [J].
Bellomo, R ;
Kellum, J ;
Ronco, C .
INTENSIVE CARE MEDICINE, 2001, 27 (11) :1685-1688
[5]   Continuous haemofiltration in the intensive care unit [J].
Bellomo, R ;
Ronco, C .
CRITICAL CARE, 2000, 4 (06) :339-345
[6]  
BELLOMO R, 1999, OXFORD TXB CRITICAL, P419
[7]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[8]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[9]   Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study [J].
Brivet, FG ;
Kleinknecht, DJ ;
Loirat, P ;
Landais, PJM ;
Bedock, B ;
Bleichner, G ;
Richard, C ;
Coste, F ;
BrunBuisson, C ;
Sicot, C ;
Tenaillon, A ;
Gajdos, P ;
Blin, F ;
Saulnier, F ;
Agostini, MM ;
Nicolas, F ;
FeryLemonnier, E ;
Staikowski, F ;
Carlet, J ;
Guivarch, G ;
Fraisse, F ;
Ricome, J ;
Tempe, JD ;
Mezzarobba, P .
CRITICAL CARE MEDICINE, 1996, 24 (02) :192-198
[10]   A phase II randomized, controlled trial of continuous hemofiltration in sepsis [J].
Cole, L ;
Bellomo, R ;
Hart, G ;
Journois, D ;
Davenport, P ;
Tipping, P ;
Ronco, C .
CRITICAL CARE MEDICINE, 2002, 30 (01) :100-106